CVRx (CVRX) Gross Profit Growth (1y) (2021 - 2026)
CVRx (CVRX) Gross Profit Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 15.59% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 17.10% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 10.88% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 12.38% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 13.54% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 20.50% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 9.82% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 4.20% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 8.95% |
| 10 | CVRx | 77.03 Mn | 12.44 Mn | 13.72 Mn | 19.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.86% |
| Mar 31, 2026 | 24.91% |
| Dec 31, 2025 | 8.25% |
| Sep 30, 2025 | 14.63% |
| Jun 30, 2025 | 15.57% |
| Mar 31, 2025 | 12.64% |
| Dec 31, 2024 | 33.24% |
| Sep 30, 2024 | 26.13% |
| Jun 30, 2024 | 24.10% |
| Mar 31, 2024 | 37.65% |
| Dec 31, 2023 | 69.14% |
| Sep 30, 2023 | 82.01% |
| Jun 30, 2023 | 108.43% |
| Mar 31, 2023 | 112.70% |
| Dec 31, 2022 | 111.93% |
| Sep 30, 2022 | 92.38% |
| Jun 30, 2022 | 73.30% |
| Mar 31, 2022 | 56.90% |
| Dec 31, 2021 | 63.35% |
| Sep 30, 2021 | 220.89% |